Neurmedix is a bio-pharmaceutical company focused on developing life-changing medicines for neurological disorders. Their pipeline includes drug candidates such as NE3170, HE3789, and HE3413, targeting diseases like Alzheimer's, multiple myeloma, prostate cancer, Parkinson's, and encephalitis. Their corporate objective is to develop innovative treatments for these conditions.